Adjunctive Benefit of Electrolytic Cleaning on Non-surgical Treatment of Peri-implantitis.

NCT ID: NCT05179746

Last Updated: 2022-06-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2024-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluate the outcomes of non-surgical therapy of peri-implantitis with the adjunctive use of electrolytic cleaning (Galvo Surge®).

The proposed protocol, focused on the non-surgical treatment of peri-implantitis, will result in a higher percentage of subjects with disease resolution (probing depts ≤ 5mm, absence of BOP and/or SOP and no further bone loss) at 1 year of follow-up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The adjunctive use of electrolytic cleaning (Galvo Surge®) in the non-surgical treatment of peri-implantitis will result in a higher reduction of probing depth than the control group.

The adjunctive use of electrolytic cleaning (Galvo Surge®) in the non-surgical treatment of peri-implantitis will result in a higher radiographic bone fill of the peri-implant defect than the control group.

The adjunctive use of electrolytic cleaning (Galvo Surge®) in the non-surgical treatment of peri-implantitis will result in a lower count of peri-implant pathogens than the control group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peri-Implantitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

With electrolytic cleaning

Mechanical debridement with ultrasonics (plastic tip) and plastic curettes

Group Type ACTIVE_COMPARATOR

Implants are decontaminated with electrolytic cleaning

Intervention Type DEVICE

Implants are decontaminated with electrolytic cleaning

Without electrolytic cleaning

Mechanical debridement with ultrasonics (plastic tip) and plastic curettes

Group Type PLACEBO_COMPARATOR

Implants are decontaminated without electrolytic cleaning

Intervention Type DEVICE

Implants are decontaminated without electrolytic cleaning

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implants are decontaminated with electrolytic cleaning

Implants are decontaminated with electrolytic cleaning

Intervention Type DEVICE

Implants are decontaminated without electrolytic cleaning

Implants are decontaminated without electrolytic cleaning

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Partially edentulous patients, rehabilitated with at least one dental implant in the maxilla or mandible;
2. Presence of Peri-implantitis;
3. No implant mobility;
4. Treated periodontal disease;
5. No systemic diseases that could influence the outcome of the therapy (i.e. uncontrolled diabetes, osteoporosis, bisphosphonate medication).
6. Non-smoker or light smoking status in smokers (\<10 cigarettes/day).

Exclusion Criteria

(1) Pregnant, lactating women and non-collaborating patients will be excluded from the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lisbon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vanessa Rocha Rodrigues

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tiago Ribeiro-Amaral, Dr

Role: PRINCIPAL_INVESTIGATOR

University of Lisbon

Paulo Macaranhas, PhD

Role: STUDY_DIRECTOR

University of Lisbon

Vanessa Rocha Rodrigues, Dr

Role: STUDY_CHAIR

University of Lisbon

Susana Noronha, PhD

Role: STUDY_DIRECTOR

University of Lisbon

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vanessa Rocha Rodrigues, Dr

Role: CONTACT

919950890 ext. +351

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Electrolytic cleaning

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SPiT-frequency I_Peri-implant Mucositis
NCT06737328 NOT_YET_RECRUITING NA